Jun-16-22 10:53AM |
Is Regeneron Absurdly Cheap or Has it Become a Value Trap?The Motley Fool |
Jun-07-22 03:25AM |
Lilly (LLY) Eczema Candidate Keeps Skin Clearance for One YearZacks Investment Research |
Jun-06-22 11:12AM |
Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2022Benzinga |
Jun-04-22 07:50AM |
Wall Street Breakfast: What Moved MarketsSeeking Alpha |
Jun-03-22 03:42AM |
Regeneron (REGN) to Buy Sanofi's Stake in Libtayo, Stock DownZacks Investment Research |
11:31AM |
Regeneron (REGN) Down 1.4% Since Last Earnings Report: Can It Rebound?Zacks Investment Research |
Jun-02-22 06:30AM |
Why Regeneron Wasn't a Healthy Stock TodayThe Motley Fool |
04:15AM |
Markets Rise Amid Strength In Tech, SoftwareBenzinga |
Jun-01-22 02:39AM |
Biotech Stock Roundup: BMY's Opdivo Updates, Pipeline Updates From REGN, BIIBZacks Investment Research |
May-31-22 02:24AM |
7 Analysts Have This to Say About Regeneron PharmaceuticalsBenzinga |
10:16AM |
Sanofi's (SNY) Dupixent Prurigo Nodularis NDA Gets Priority TagZacks Investment Research |
May-26-22 07:42AM |
Why Regeneron Investors Shouldn't Fear Its Patent CliffThe Motley Fool |
May-25-22 12:05PM |
SpringWorks (SWTX) Down Despite Desmoid Tumors Study Meeting GoalZacks Investment Research |
10:06AM |
Biotech Stock Roundup: ETTX Up on Acquisition Deal, REGN Offers UpdatesZacks Investment Research |
May-25-22 01:09AM |
Sanofi, Regeneron's Dupixent Gets FDA Nod for 4th Indication (Revised)Zacks Investment Research |
May-23-22 12:26PM |
Regeneron's (REGN) Evkeeza Positive in Late-Stage StudyZacks Investment Research |
10:33AM |
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022Benzinga |
May-23-22 10:20AM |
Sanofi, Regeneron's Dupixent Gets FDA Nod for 4th IndicationZacks Investment Research |
May-18-22 12:51PM |
The Correction In Biopharmaceutical Stocks Is Likely OverSeeking Alpha |
May-13-22 08:42AM |
The Zacks Analyst Blog Highlights Regeneron, Vertex, Intercept Pharmaceuticals, and Biohaven PharmaceuticalZacks Investment Research |
May-12-22 09:11AM |
Biotech Stock Roundup: REGN, VRTX Earnings Update, BHVN Up on Regulatory NewsZacks Investment Research |
09:05AM |
Is Regeneron In Trouble After Sales Declined 40% In a Single Quarter?The Motley Fool |
May-11-22 12:38PM |
Kodiak Sciences (KOD) Q1 Loss Widens, Eye Candidate in FocusZacks Investment Research |
May-10-22 10:56AM |
Bayer (BAYRY) Earnings & Revenues Surpass Estimates in Q1Zacks Investment Research |
06:20AM |
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?Zacks Investment Research |
May-06-22 03:02AM |
Intellia (NTLA) Q1 Loss Wider Than Expected, Revenues BeatZacks Investment Research |
11:37AM |
Ultragenyx's (RARE) Q1 Earnings & Revenues Miss EstimatesZacks Investment Research |
May-04-22 11:54AM |
Regeneron (REGN) Q1 Earnings Beat, COVID Antibody Sales AffectedZacks Investment Research |
07:45AM |
Regeneron (REGN) Q1 Earnings and Revenues Beat EstimatesZacks Investment Research |
May-04-22 06:20AM |
Should You Invest in the iShares Biotechnology ETF (IBB)?Zacks Investment Research |
May-02-22 06:22AM |
The Zacks Analyst Blog Highlights Novo Nordisk, Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and BiogenZacks Investment Research |
06:20AM |
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?Zacks Investment Research |
Apr-29-22 12:33PM |
Alnylam (ALNY) Misses on Q1 Earnings, Lowers '22 Revenue ViewZacks Investment Research |
Apr-28-22 10:52AM |
Sanofi (SNY) Q1 Earnings Top, Vaccines Recover, CHC Sales RiseZacks Investment Research |
09:00AM |
Can a decades-old antidepressant keep COVID-19 patients out of the hospital?MarketWatch |
Apr-28-22 06:20AM |
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?Zacks Investment Research |
Apr-27-22 03:03AM |
Regeneron (REGN) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research |
07:11AM |
Can a decades-old antidepressant keep COVID-19 patients out of the hospital?MarketWatch |
Apr-26-22 07:14AM |
Can a decades-old antidepressant keep COVID-19 patients out of the hospital?MarketWatch |
Apr-25-22 05:19AM |
Can a decades-old antidepressant keep COVID-19 patients out of the hospital?MarketWatch |
12:49PM |
Can a decades-old antidepressant keep COVID-19 patients out of the hospital?MarketWatch |
Apr-25-22 11:46AM |
Roche's (RHHBY) Q1 Sales Grow on COVID-19 Tests, New DrugsZacks Investment Research |
Apr-20-22 12:54PM |
Biotech Stock Roundup: NKTR Plunges on Deal Termination, REGN Offers Update & MoreZacks Investment Research |
11:16AM |
Regeneron (REGN) to Buy Checkmate Pharmaceuticals for $250MZacks Investment Research |
Apr-20-22 07:40AM |
3 Top Biotech Stocks Ready for a Bull RunThe Motley Fool |
Apr-19-22 03:43AM |
Why Adaptimmune Therapeutics, Agenus, and Sorrento Therapeutics Popped TodayThe Motley Fool |
02:58AM |
Why Checkmate Pharmaceuticals Stock Is Rocketing Higher TodayThe Motley Fool |
Apr-19-22 09:15AM |
Amgen's (AMGN) Stelara Biosimilar Meets Psoriasis Study GoalZacks Investment Research |
09:11AM |
Hot Penny Stocks to Buy? 3 to Watch As CMPI Stock Shoots Up 320%PennyStocks |
Apr-18-22 12:12PM |
Regeneron (REGN) REGEN-COV BLA Review Extended by 3 MonthsZacks Investment Research |